73 related articles for article (PubMed ID: 34615721)
1. Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era.
Dermawan JK; Kelly C; Gao Z; Smith S; Jadeja B; Singer S; Tap WD; Chi P; Antonescu CR
Clin Cancer Res; 2023 Oct; 29(19):3974-3985. PubMed ID: 37477937
[TBL] [Abstract][Full Text] [Related]
2. The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry.
Teranishi R; Takahashi T; Sato S; Sakurai K; Kishi K; Hosogi H; Nakai T; Kurokawa Y; Fujita J; Nishida T; Hirota S; Tsujinaka T
Gastric Cancer; 2024 Mar; 27(2):355-365. PubMed ID: 38146035
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Pasquali S; Palmerini E; Quagliuolo V; Martin-Broto J; Lopez-Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz-Beveridge R; Ferraresi V; Lugowska I; Infante G; Braglia L; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Miceli R; Casali PG; Gronchi A
Cancer; 2022 Jan; 128(1):85-93. PubMed ID: 34643947
[TBL] [Abstract][Full Text] [Related]
4. Hemodialysis and imatinib: Plasma levels, efficacy and tolerability in a patient with metastatic GIST - Case report.
De Luca I; Miliziano D; Guerra G; Colombo R; Morosi C; Sposito C; Fiore M; Venturelli E; Sangalli C; Casali PG; Cavalleri A; Fumagalli E
Heliyon; 2024 Apr; 10(7):e28494. PubMed ID: 38596050
[TBL] [Abstract][Full Text] [Related]
5. Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective.
Lopes David BB; Nazareth Aguiar Junior P; Costa E Silva M; Dienstmann R; Gil Ferreira C; Serrano C
JCO Glob Oncol; 2023 Sep; 9():e2300070. PubMed ID: 37856732
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours.
Golčić M; Jones RL; Huang P; Napolitano A
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627109
[TBL] [Abstract][Full Text] [Related]
7.
Joensuu H
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568695
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Supplementation during Intensive Care Unit Stay Is Associated with Improved Outcomes in Critically Ill Patients with Sepsis: A Cohort Study.
Yang B; Zhu Y; Zheng X; Li T; Niu K; Wang Z; Lu X; Zhang Y; Shen C
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447250
[TBL] [Abstract][Full Text] [Related]
9. Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib.
Brackert S; Polson K
J Adv Pract Oncol; 2023 May; 14(4):317-328. PubMed ID: 37313282
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of a Radiomics Nomogram Model Based on Contrast-Enhanced Computed Tomography for KIT Exon 9 Gene Mutation in Gastrointestinal Stromal Tumors.
Wei Y; Lu Z; Ren Y
Technol Cancer Res Treat; 2023; 22():15330338231181260. PubMed ID: 37296525
[TBL] [Abstract][Full Text] [Related]
11. SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).
Serrano C; Álvarez R; Carrasco JA; Marquina G; Martínez-García J; Martínez-Marín V; Sala MÁ; Sebio A; Sevilla I; Martín-Broto J
Clin Transl Oncol; 2023 Sep; 25(9):2707-2717. PubMed ID: 37129716
[TBL] [Abstract][Full Text] [Related]
12. KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.
Joensuu H; Wardelmann E; Eriksson M; Reichardt A; Hall KS; Schütte J; Cameron S; Hohenberger P; Sihto H; Jost PJ; Lindner LH; Bauer S; Nilsson B; Kallio R; Pesonen T; Reichardt P
Clin Cancer Res; 2023 Sep; 29(17):3313-3319. PubMed ID: 37014660
[TBL] [Abstract][Full Text] [Related]
13. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
Naito Y; Nishida T; Doi T
Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Gastrointestinal Stromal Tumors and Their Impact on Systemic Therapy Decision.
Unk M; Jezeršek Novaković B; Novaković S
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900287
[TBL] [Abstract][Full Text] [Related]
15. Identification of Thiazolo[5,4-
Nam Y; Kim C; Han J; Ryu S; Cho H; Song C; Kim ND; Kim N; Sim T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612139
[TBL] [Abstract][Full Text] [Related]
16. GnRH-agonist pretreatment in hormone replacement therapy improves pregnancy outcomes in women with male-factor infertility.
Yu J; Chen P; Luo Y; Lv M; Lou L; Xiao Q; Wang L; Chen J; Bai M; Zhang Z
Front Endocrinol (Lausanne); 2022; 13():1014558. PubMed ID: 36213273
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study.
Tsukamoto S; Honma Y; Shoji H; Hirano H; Inoue M; Takamizawa Y; Moritani K; Imaizumi J; Kanemitsu Y
BJS Open; 2022 May; 6(3):. PubMed ID: 35594280
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
Vincenzi B; Napolitano A; Fiocco M; Mir O; Rutkowski P; Blay JY; Reichardt P; Joensuu H; Fumagalli E; Gennatas S; Hindi N; Nannini M; Spalato Ceruso M; Italiano A; Grignani G; Brunello A; Gasperoni S; De Pas T; Badalamenti G; Pantaleo MA; van Houdt WJ; IJzerman NS; Steeghs N; Gelderblom H; Desar IME; Falkenhorst J; Silletta M; Sbaraglia M; Tonini G; Martin-Broto J; Hohenberger P; Le Cesne A; Jones RL; Dei Tos AP; Gronchi A; Bauer S; Casali PG
Clin Cancer Res; 2022 Apr; 28(8):1672-1679. PubMed ID: 34615721
[TBL] [Abstract][Full Text] [Related]
19. The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice.
Rutkowski P; Ziętek M; Cybulska-Stopa B; Streb J; Głuszek S; Jankowski M; Łopacka-Szatan K; Las-Jankowska M; Hudziec P; Klimczak A; Olesiński T; Świtaj T; Koseła-Paterczyk H; Bylina E; Osuch C
Eur J Surg Oncol; 2021 May; 47(5):1191-1195. PubMed ID: 32826113
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
